Blog

OpenSpecimen and COVID19

“According to Darwin’s Origin of Species, it is not the most intellectual of the species that survives; it is not the strongest that survives; but the species that survives is the one that is able best to adapt and adjust to the changing environment in which it finds itself.” – Leon C. Megginson The pandemic has […]

Establishing a Biobank in Singapore

The Human Biomedical Research Act (HBRA) of Singapore regulates all research that involves human biospecimen in Singapore. Institutions or individuals aiming to establish a biobank under SingHealth must adopt best practices from established biobanks and ISBER. Recently, the team from SingHealth published a poster explaining the “Best Practices for Establishing a Biobank in Singapore Research Institution.” Stages […]

Winship Cancer (Emory University) selects OpenSpecimen as Biobanking LIMS

The Winship Cancer Institute Clinical Trial office (CTO) conducts high-quality clinical trials involving cancer patients. It conducts over 250 clinical trials enrolling roughly 800 patients per year. In May 2016, they adopted OpenSpecimen as their biobanking LIMS to manage their biospecimens due to its highly configurable features including REST APIs to integrate with . Refer to […]

SpecimenCatalog: Sharing Data with Researchers

Most biobanks struggle with improving “utilization ratios” of their collections. The utilization ratio is the ratio of the specimen collected vs. distributed – which is critical for a biobank’s “sustenance.” SpecimenCatalog helps with sharing biospecimen data with researchers. It provides an easy-to-use interface for researchers to look for specimens of interest and submit requests. Catalogs […]

How Biobanking LIMS helped the University of California achieve CAP accreditation?

Research in precision medicine requires a continuous supply of high-quality biospecimens. But as the saying goes- “Garbage in garbage out”, meaningful conclusions from the studies can only be drawn when the researchers are assured that the materials used in their research were of good quality. A survey(1) conducted by the National Cancer Institute (NCI) funded cancer […]

university of california cap accreditation using biobanking lims

Biobanking as a Newsletter- January’20

Here is your monthly curated pick of biobanking news, jobs, and events from across the globe. Fresh of the Press Australian biobank repatriates hundreds of ‘legacy’ Indigenous blood samples Clinical trials planned for brain tumor ‘GPS’ maps at Case Western Reserve University Geisinger’s biobank surpasses 250,000 patients NIH establishes Infectious Diseases Clinical Research Consortium AI shows promise for breast cancer […]

Is OpenSpecimen CFR Part-11 Compliant?

The short answer is Yes. However, it is important to note that the software itself cannot be compliant. Rather, it is the implementation and use of software that determines compliance. It is achieved only when a study has the procedures, policies, documentation, training, and validation that meets Part-11 requirements. An FDA auditor will review all […]